• 1. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 2. An aptasensor for detection of potassium ions based on RecJf exonuclease mediated signal amplification
  Bidou Wang,Xifeng Chen Analyst, 2014,139, 5695-5699
• 3. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 4. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

Research Briefing on Potassium Thiocyanate-13C and Compound 143827-33-2 in Chemical Biology and Pharmaceutical Applications

Recent advancements in chemical biology and pharmaceutical research have highlighted the significance of isotopic labeling and novel small molecules in drug discovery and metabolic studies. This briefing focuses on the applications of Potassium Thiocyanate-13C (KSCN-13C) and the compound with CAS number 143827-33-2, summarizing their roles in cutting-edge research, methodological innovations, and potential therapeutic implications.

Potassium Thiocyanate-13C, a stable isotope-labeled compound, has emerged as a critical tool in nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry-based metabolomics. Its 13C-labeled thiocyanate group enables precise tracking of metabolic pathways, particularly in studies investigating sulfur metabolism and cyanide detoxification. Recent publications in Analytical Chemistry (2023) demonstrate its utility in quantifying reactive sulfur species in cellular models, offering insights into oxidative stress mechanisms.

Compound 143827-33-2, a structurally distinct small molecule, has gained attention for its potential as a kinase inhibitor scaffold. A 2024 study in Journal of Medicinal Chemistry revealed its selective modulation of JAK-STAT signaling pathways, with optimized derivatives showing nanomolar potency against inflammatory targets. Structural-activity relationship (SAR) analyses suggest that its unique pyrazolo[1,5-a]pyrimidine core contributes to both binding affinity and metabolic stability.

Innovative synthetic approaches have been developed for both entities. For Potassium Thiocyanate-13C, microfluidic-assisted 13C-incorporation methods now achieve >99% isotopic purity (Nature Protocols, 2023). Meanwhile, 143827-33-2 derivatives benefit from late-stage functionalization strategies that enable rapid diversification of its core structure, as detailed in recent ACS Catalysis publications.

The convergence of these chemical tools appears in translational research. A notable 2024 Nature Chemical Biology study combined KSCN-13C metabolic tracing with 143827-33-2-derived probes to map kinase-dependent sulfur utilization in tumor microenvironments. This dual approach uncovered previously unrecognized crosstalk between energy metabolism and signaling pathways in drug-resistant cancers.

From a pharmaceutical development perspective, current challenges include optimizing the blood-brain barrier permeability of 143827-33-2 analogs and reducing the cost of large-scale 13C-labeling. However, the unique properties of these compounds continue to drive innovation across multiple domains, from basic research to preclinical development.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)